rhinovirus
rv
associ
exacerb
cystic
fibrosi
cf
asthma
copd
grow
evid
suggest
involv
interferon
ifn
pathway
rvassoci
morbid
asthma
copd
mechan
rvtrigger
exacerb
cf
poorli
understood
pilot
studi
assess
antivir
respons
cf
healthi
bronchial
epitheli
cell
bec
rv
infect
measur
level
ifn
pattern
recognit
receptor
prr
ifnstimul
gene
isg
upon
infect
major
minor
group
rv
poli
ic
stimul
major
group
rv
infect
cf
bec
result
trend
toward
diminish
ifn
respons
level
ifn
prr
isg
comparison
healthi
bec
contrari
major
group
rv
ifn
pathway
induct
upon
minor
group
rv
infect
significantli
increas
level
ifn
prr
cf
bec
compar
healthi
bec
rhinovirus
rv
small
positivesens
ssrna
virus
belong
picornavirida
famili
rv
serotyp
classifi
major
minor
group
depend
surfac
receptor
use
infect
target
cell
rv
serotyp
strain
belong
major
group
use
receptor
intercellular
adhes
molecul
minor
group
rv
strain
bind
lowdens
lipoprotein
receptor
ldlr
target
cell
caus
agent
common
cold
acut
respiratori
tract
infect
children
rv
one
major
caus
morbid
mortal
addit
rv
predomin
agent
associ
pulmonari
exacerb
cf
lung
diseas
detect
virusassoci
cf
exacerb
mechan
acut
virusmedi
exacerb
cf
far
poorli
understood
other
report
recent
primari
cf
bronchial
epitheli
cell
bec
increas
suscept
respiratori
viru
infect
rv
parainfluenza
viru
confirm
find
ex
vivo
bronchoalveolar
lavag
bal
sampl
collect
rvinfect
cf
children
rv
load
elev
comparison
control
patient
rv
also
respons
virusinduc
asthma
exacerb
defect
interferon
ifn
type
type
iii
product
bronchial
airway
epithelium
upon
rv
infect
identifi
contribut
mechan
behind
impair
rv
control
asthmat
adult
children
work
two
group
studi
mechan
viral
control
ifn
induct
bec
macrophag
collect
patient
chronic
obstruct
pulmonari
diseas
copd
led
controversi
result
grow
bec
airliquid
interfac
ali
schneider
et
al
show
increas
ifn
product
upon
rv
infect
despit
cell
show
impair
viral
control
increas
proinflammatori
phenotyp
hand
mallia
et
al
found
lower
ifn
respons
upon
infect
rv
bal
macrophag
copd
patient
compar
control
subject
sinc
ifn
pathway
involv
defect
control
rv
infect
bec
asthmat
copd
patient
decid
evalu
ifn
respons
cf
bec
challeng
rv
major
minor
group
respect
also
aim
assess
baselin
express
induct
pattern
recognit
receptor
prr
engag
sens
rv
includ
tolllik
receptor
melanoma
differentiationassoci
protein
retino
acid
induc
gene
rigi
level
ifnstimul
gene
isg
dsrna
protein
kinas
r
pkr
synthetas
mxa
myxoviru
resist
gene
viperin
viru
inhibitori
protein
endoplasm
reticulumassoci
ifn
induc
also
measur
final
inflammatori
respons
mediat
rv
infect
cf
bec
also
quantifi
measur
cytokin
releas
establish
primari
bec
cultur
recruit
healthi
cf
volunt
univers
hospit
bern
clinic
characterist
particip
use
studi
present
elsewher
reproduc
clariti
eas
refer
tabl
exclus
criteria
bleed
tendenc
therapi
anticoagul
andor
immunosuppress
agent
control
group
steroid
use
within
past
three
month
atopi
addit
exclus
criteria
studi
approv
ethic
committe
canton
bern
zurich
switzerland
inform
consent
obtain
studi
particip
andor
caregiv
bec
cf
control
subject
grown
bronchial
brush
perform
mm
brush
conm
usa
describ
primari
submerg
cultur
bec
obtain
seed
freshli
brush
cell
bronchial
epitheli
growth
medium
begm
lonza
switzerland
supplement
singl
quot
lonza
switzerland
describ
previous
virus
amplifi
titrat
ohio
hela
cell
eccac
uk
bec
infect
rv
h
multipl
infect
wash
three
time
pb
life
technolog
usa
fresh
medium
ad
plate
incub
h
harvest
cell
treat
parallel
infect
media
im
polyinosinicpolycytidyl
acid
poli
ic
concentr
invivogen
usa
sinc
peak
rv
replic
observ
ca
h
postinfect
total
rna
supernat
harvest
h
postinfect
analysi
total
rna
purif
done
use
nucleospin
rna
ii
kit
machereynagel
switzerland
synthesi
cdna
perform
omniscript
rt
kit
qiagen
usa
follow
manufactur
protocol
rtpcr
measur
done
taqman
fast
univers
pcr
master
mix
fast
sybr
green
master
mix
fast
real
time
pcr
system
appli
biosystem
usa
sequenc
primer
probe
depict
tabl
analyz
mrna
express
level
ifn
prr
isg
method
use
mrna
express
level
normal
rrna
protein
level
measur
use
duoset
elisa
develop
kit
r
usa
follow
detect
limit
pgml
pgml
pgml
statist
analysi
perform
use
graphpad
prism
graphpad
softwar
inc
usa
data
analyz
normal
distribut
use
kolmogorovsmirnov
test
normal
distribut
pair
data
analyz
oneway
anova
tukey
post
hoc
test
pair
data
nonnorm
distribut
analyz
friedman
dunn
post
hoc
test
analysi
unpair
data
perform
twoway
anova
bonferroni
post
hoc
test
normal
distribut
unpair
data
nonnorm
distribut
analyz
kruskalw
test
follow
dunn
post
hoc
test
p
b
consid
statist
signific
normal
distribut
data
shown
mean
sem
nonparametr
data
shown
median
iqr
order
determin
antivir
respons
mediat
ifn
function
cf
bec
measur
mrna
express
level
cf
control
bec
infect
infect
cf
bec
major
group
rv
observ
nonsignific
trend
toward
lower
level
fig
fig
fig
comparison
healthi
bec
contrast
ifn
respons
cf
bec
compar
healthi
bec
upon
infect
minor
group
rv
significantli
increas
fig
fig
observ
differ
experi
poli
ic
strong
ifn
inducerwhich
gave
similar
level
measur
ifn
cf
bec
healthi
bec
fig
c
next
evalu
express
prr
involv
sens
innat
immun
respons
rv
constitut
mrna
level
viral
sensor
rigi
differ
cf
compar
control
cell
data
shown
observ
nonsignific
trend
toward
decreas
express
rigi
fig
fig
upon
infect
major
group
viru
cf
cell
compar
control
interestingli
cf
bec
infect
level
rigi
significantli
increas
fig
found
trend
toward
elev
express
fig
comparison
healthi
bec
interestingli
poli
ic
stimul
cf
bec
induc
significantli
higher
level
prr
test
cf
bec
comparison
healthi
bec
fig
infect
cell
activ
prr
subsequ
ifn
product
launch
antivir
effector
mechan
lead
express
numer
isg
thu
analyz
express
select
isg
name
pkr
viperin
mxa
upon
rv
infect
poli
ic
stimul
found
significantli
lower
express
viperin
fig
tendenc
lower
express
mxa
fig
cf
vs
healthi
bec
infect
also
significantli
higher
express
pkr
fig
mxa
fig
cf
bec
stimul
poli
ic
comparison
control
observ
differ
isg
test
cf
healthi
bec
infect
minor
group
fig
order
evalu
inflammatori
respons
cf
bec
rv
infect
measur
level
cytokin
baselin
condit
upon
infect
stimul
poli
ic
inflammatori
cytokin
produc
bec
upon
rv
infect
andor
poli
ic
stimul
gener
increas
cf
cell
inde
level
nonsignific
tendenc
constitut
higher
significantli
increas
upon
poli
ic
treatment
fig
cf
cell
compar
control
also
comparison
control
bec
cf
bec
significantli
higher
level
baselin
condit
poli
ic
stimul
fig
level
produc
cf
bec
significantli
higher
baselin
comparison
control
bec
contrast
cf
bec
produc
significantli
less
comparison
control
bec
stimul
poli
ic
fig
rv
infect
associ
pulmonari
exacerb
asthma
copd
cf
lung
diseas
grow
evid
impair
antivir
respons
mediat
ifn
pathway
may
contribut
increas
suscept
toward
rv
infect
asthmat
copd
also
author
suggest
rv
infect
cf
patient
exacerb
lower
airway
symptom
promot
outgrowth
p
aeruginosa
interestingli
stelzerbraid
et
al
report
recent
cf
pulmonari
exacerb
trigger
rv
associ
presenc
bacteri
pathogen
assess
multiplex
rtpcr
thu
exact
contribut
mechan
p
aeruginosa
rvinduc
exacerb
cf
deserv
investig
level
prr
engag
sens
rv
measur
upon
infect
major
minor
group
rv
poli
ic
stimul
line
decreas
ifn
respons
cf
bec
infect
major
group
rv
observ
nonsignific
trend
toward
decreas
induct
rigi
cf
bec
comparison
healthi
bec
infect
major
group
rv
interestingli
found
higher
induct
rigi
cf
vs
healthi
bec
upon
treatment
ifn
induc
poli
ic
level
isg
observ
decreas
induct
viperin
mxa
cf
bec
comparison
healthi
bec
infect
major
group
rv
observ
accord
find
impair
ifn
prr
express
upon
infect
cf
bec
compar
control
baselin
rv
infectioninduc
isg
express
similar
cf
healthi
bec
challeng
minor
group
rv
consist
increas
prr
level
induc
poli
ic
treatment
poli
ic
treatment
cf
bec
also
led
higher
express
isg
test
pkr
mxa
suggest
dysfunct
signal
pathway
involv
dsrna
prr
knowledg
first
report
describ
hyperrespons
cf
cell
prr
stimul
infect
cf
bec
major
minor
group
rv
exert
opposit
ifn
respons
comparison
healthi
bec
elev
inflammatori
respons
trigger
infect
similar
major
minor
group
rv
inflammatori
cytokin
produc
cf
bec
upon
poli
ic
stimul
alter
demonstr
elev
level
proinflammatori
cytokin
also
found
increas
constitut
releas
cf
bec
compar
healthi
bec
observ
accord
previou
report
attribut
intrins
inflammatori
phenotyp
cf
airway
cell
compat
ex
vivo
data
show
elev
inflammatori
cytokin
concentr
bal
stabl
cf
patient
line
elev
prr
isg
cf
bec
stimul
poli
ic
poli
ic
stimul
led
hyperinflammatori
respons
cf
bec
comparison
healthi
bec
evidenc
elev
level
howev
sinc
cytokin
constitut
elev
cf
bec
unclear
yet
increas
inflammatori
respons
cf
bec
poli
ic
sole
due
poli
ic
stimul
addit
effect
alreadi
elev
baselin
level
addit
experi
requir
inflammatori
stimuli
order
address
question
contrast
level
upon
stimul
poli
ic
significantli
decreas
cf
cell
comparison
control
cell
observ
possibl
explain
fact
regul
gene
transcript
control
ifn
pathway
healthi
cell
respons
major
minor
group
rv
evalu
group
studi
wang
et
al
gave
similar
antivir
respons
healthi
bec
line
data
report
two
group
minor
group
rv
higher
induc
comparison
major
group
rv
recent
schuler
et
al
found
major
minor
group
rv
induc
distinct
antivir
signal
inflammatori
cytokin
respons
primari
healthi
macrophag
rv
frequent
detect
virus
virusinduc
cf
exacerb
grow
number
studi
report
sever
viral
pathogen
trigger
cf
exacerb
children
adult
includ
influenza
viru
respiratori
syncyti
viru
parainfluenza
viru
coronaviru
adenoviru
metapneumoviru
virus
induc
distinct
pathogenesi
lung
therefor
conceiv
mechan
virusinduc
cf
exacerb
least
part
virusspecif
line
hypothesi
recent
studi
ramirez
et
al
demonstr
cf
exacerb
trigger
rv
influenza
viru
led
distinct
antivir
respons
therefor
would
interest
test
vitro
system
clinic
relev
respiratori
virus
influenza
respiratori
syncyti
viru
summari
report
differenti
ifn
pathway
respons
cf
bec
infect
major
minor
group
rv
major
group
rv
infect
lead
diminish
ifn
pathway
respons
level
ifn
prr
isg
howev
ifn
pathway
induct
cf
bec
upon
minor
group
rv
infect
higher
healthi
bec
also
cf
bec
intrins
inflammatori
phenotyp
assess
constitut
elev
releas
cytokin
final
sinc
studi
base
small
number
subject
data
need
confirm
larg
studi
popul
